CELH

Celsius Holdings, Inc. - Q1 2008 10-Q Summary

Business Context and Reporting Period

This filing covers the quarterly period ended March 31, 2008. Celsius Holdings, Inc. operates as a holding company with no direct operations, conducting business through wholly-owned subsidiaries Celsius, Inc. and Celsius Netshipments, Inc. The company manufactures and markets "Celsius," a functional calorie-burning beverage. The company is classified as a smaller reporting company and a shell company prior to its reverse merger with Elite FX, Inc. in January 2007.

Key Financial Metrics

Note: Working Capital calculated as Current Assets ($1,558,421) minus Current Liabilities ($3,376,380).

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 121.7% to $533,382, driven by new distributorships (including Walgreens in several states) and re-orders from established partners.
• Margin Expansion: Gross margin improved to 44.0% from 27.2%, attributed to a product mix shift from glass bottles to cans and improved production efficiencies.
• Expense Increases: Selling and marketing expenses rose 146% to $848,216 due to increased employee costs, advertising, and sampling. General and administrative expenses increased 50% to $464,905, largely due to $120,000 in stock-based compensation for an international distributor and $110,000 for clinical studies.
• One-Time Items: The prior year (Q1 2007) included a $500,000 termination of contract expense which was absent in Q1 2008.
• Interest Expense: Total other expense increased to $103,210 from $30,905, driven by higher interest liabilities and $55,000 in debt discount amortization.

Outlook, Risks, and Management Commentary

Going Concern: The filing explicitly states that recurring losses, a stockholders' deficit, and negative working capital raise substantial doubt about the company's ability to continue as a going concern. Management estimates a need for an additional $5.0 million to implement its business plan over the next 12 months.

Liquidity and Financing:

• The company relies on two lines of credit: a $500,000 factoring agreement for receivables (outstanding balance $232,772) and a $500,000 inventory financing line (outstanding balance $238,414).
• Significant related party debt exists, including $678,031 owed to a shareholder and $228,494 owed to the CEO (including accrued salary).
• A $1.5 million convertible debenture with Golden Gate Investors, Inc. is outstanding, with potential for three additional tranches totaling $6 million.

Risks:

• Product Concentration: Substantially all revenue is derived from the single Celsius beverage brand.
• Supplier Concentration: The company relies on single suppliers for raw materials and bottling capacity.
• Intellectual Property: Success depends on protecting trademarks; competitors may attempt to replicate the product.
• Key Personnel: The company is heavily dependent on its CEO, COO, and CFO.

Subsequent Events:

• On April 4, 2008, the company refinanced a $250,000 note with CD Financial, LLC and secured an additional $500,000 in financing.
• On April 7, 2008, the company collected a $400,100 subscription receivable.

Investor Verification Checklist

• Capital Adequacy: Verify the status of the $5.0 million financing requirement and the likelihood of securing the remaining tranches from Golden Gate Investors.
• Debt Covenants: Review the terms of the factoring and inventory lines of credit for potential default triggers given the negative working capital.
• Related Party Transactions: Assess the repayment terms and interest rates on the $906,525 owed to related parties, specifically the accrued CEO salary.
• Dilution Risk: Evaluate the potential dilution from the $6 million debenture agreement with Golden Gate Investors and the $14.6 million potential sale to Fusion Capital.
• Revenue Sustainability: Confirm the retention of new distributors (e.g., Walgreens) and the stability of the international customer deposit ($391,329).